ABC | Volume 111, Nº2, August 2018

Short Editorial Henz & Leite Atrial fibrillation and cryptogenic thromboembolic events Arq Bras Cardiol. 2018; 111(2):132-133 1. Ustrell X, Pelisé A. Cardiac workup of ischemic stroke. Curr Cardiol Rev. 2010;6(3):175–83. 2. Adams H, Bendixen BH, Kapelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Stroke. 1993;24(1):35–41 3. Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O’Donel MJ, et al. Embolic strokes of undetermined source: The case for a new clinical construct. Lancet Neurol. 2014;13(4):429–38. 4. Li L, Yiin GS, Geraghty OS, Schulz UG, Kuker W, Mehta Z, et al. Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: A population-based study. Lancet Neurol. 2015;14(9):903–13. 5. Ntaios G, Vemmos K, Lijo GY, Koroboki E, Manios E, Vemmou A, et al. Risk Stratification for Recurrence and Mortality in Embolic Stroke of Undetermined Source. Stroke. 2016;47(9):2278–85. 6. Sanna T, Ziegler PD, Crea F. Detection andmanagement of atrial fibrillation after cryptogenic stroke or embolic stroke of undetermined source. Clin Cardiol. 2018;41(3):426–32. 7. KernanWN, Ovbiagele B, BlackHR, BravataDM, ChimowitzMI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline for healthcare professionals from the American Heart Association/American. Stroke Association. 2014;45(7):2160-236 8. Gladstone DJ. et al. Atrial Fibrillation in Patients with Cryptogenic Stroke. N Engl J Med. 2014;370(26):2467–77. 9. Sanna T, Dienner HC, Passman RS, Di Lazaro V, Bernstein RA, MorelloCA, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014; 370(26):2478–86. 10. Sampaio RF, Gomes IC, Sternick EB. Artigo Original AVC Isquêmico agudo criptogênico:avaliaçãododesempenhodeumnovosistemademonitorização contínua e prolongada. Arq Bras Cardiol. 2018; 111(2):122-131. 11. Glotzer TV, Hellkamps AB, Zimmerman J, Swoeney MO, Yee R, Marinchak R, et al. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: Report of the atrial diagnostics ancillary study of theMOde Selection Trial (MOST). Circulation. 2003;107(12):1614–19. 12. Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hillker C, et al. The Relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk the trends study. Circ Arrhythm Electrophysiol. 2009;2(5):474–80. 13. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capurci A, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366(2):120-9. 14. TomitaH,SasakiS,HagüJ,MetokiN.Covertatrialfibrillationandatrialhigh-rate episodesasapotentialcauseofembolicstrokesofundeterminedsource:Their detection and possiblemanagement strategy. J Cardiology. 2018;72(1):1–9. 15. Brambatti M, Connolly SJ, Gold MR, Morillo CA,Capucci A, Muto C, et al. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation. 2014;129(21):2094–99. 16. Van Gelder IC, Healy JS, Grijns HJ, Wang J, Hohnloser SH, Gold MR. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart J. 2017;38(17):1339–144. References This is an open-access article distributed under the terms of the Creative Commons Attribution License 133